35.66
Atricure Inc stock is traded at $35.66, with a volume of 305.36K.
It is up +2.56% in the last 24 hours and down -1.90% over the past month.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
See More
Previous Close:
$34.77
Open:
$34.73
24h Volume:
305.36K
Relative Volume:
0.60
Market Cap:
$1.77B
Revenue:
$499.95M
Net Income/Loss:
$-36.36M
P/E Ratio:
-46.31
EPS:
-0.77
Net Cash Flow:
$24.22M
1W Performance:
-4.19%
1M Performance:
-1.90%
6M Performance:
-6.55%
1Y Performance:
+36.05%
Atricure Inc Stock (ATRC) Company Profile
Name
Atricure Inc
Sector
Industry
Phone
513-755-4100
Address
7555 INNOVATION WAY, MASON, OH
Compare ATRC with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
ATRC
Atricure Inc
|
35.66 | 1.80B | 499.95M | -36.36M | 24.22M | -0.77 |
![]()
ISRG
Intuitive Surgical Inc
|
454.52 | 168.15B | 9.15B | 2.63B | 1.99B | 7.17 |
![]()
BDX
Becton Dickinson Co
|
191.26 | 53.93B | 21.39B | 1.61B | 2.55B | 5.56 |
![]()
RMD
Resmed Inc
|
273.81 | 39.68B | 5.15B | 1.40B | 1.65B | 9.51 |
![]()
ALC
Alcon Inc
|
78.91 | 38.70B | 10.03B | 1.07B | 1.39B | 2.17 |
![]()
WST
West Pharmaceutical Services Inc
|
247.54 | 17.53B | 2.96B | 487.70M | 344.00M | 6.68 |
Atricure Inc Stock (ATRC) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Dec-17-24 | Resumed | JP Morgan | Overweight |
Apr-23-24 | Upgrade | Oppenheimer | Perform → Outperform |
Oct-23-23 | Initiated | JMP Securities | Mkt Outperform |
Sep-29-23 | Initiated | UBS | Buy |
Aug-05-21 | Downgrade | Oppenheimer | Outperform → Perform |
Dec-18-20 | Reiterated | Needham | Buy |
Nov-06-20 | Reiterated | Needham | Buy |
Apr-07-20 | Initiated | Oppenheimer | Outperform |
Feb-06-20 | Initiated | BTIG Research | Buy |
Jan-24-20 | Reiterated | Needham | Buy |
Aug-13-19 | Downgrade | Northland Capital | Outperform → Market Perform |
Apr-12-19 | Initiated | JP Morgan | Overweight |
Oct-04-18 | Reiterated | Needham | Buy |
Aug-02-18 | Reiterated | Needham | Buy |
Aug-02-18 | Reiterated | Stifel | Buy |
Jun-18-18 | Reiterated | Needham | Buy |
Apr-27-18 | Reiterated | Needham | Buy |
Jan-16-18 | Reiterated | Needham | Buy |
Nov-02-17 | Reiterated | Needham | Buy |
Jul-28-17 | Reiterated | Needham | Buy |
May-30-17 | Resumed | Piper Jaffray | Overweight |
Jun-30-16 | Resumed | JMP Securities | Mkt Outperform |
Oct-28-15 | Reiterated | Needham | Buy |
Oct-06-15 | Reiterated | Canaccord Genuity | Buy |
Oct-06-15 | Reiterated | Needham | Buy |
View All
Atricure Inc Stock (ATRC) Latest News
AtriCure Inc.’s volatility index tracking explained2025 Key Highlights & Reliable Price Breakout Signals - Newser
Using economic indicators to assess AtriCure Inc. potentialJuly 2025 Closing Moves & Consistent Income Trade Ideas - Newser
Is AtriCure Inc. still worth holding after the dipJuly 2025 Fed Impact & AI Optimized Trading Strategy Guides - Newser
Applying Wyckoff theory to AtriCure Inc. stockJuly 2025 Drop Watch & Growth Focused Stock Reports - Newser
What recovery options are there for AtriCure Inc.2025 Key Lessons & Free Verified High Yield Trade Plans - Newser
AtriCure (NASDAQ:ATRC) pulls back 4.2% this week, but still delivers shareholders respectable 40% return over 1 year - simplywall.st
Is AtriCure Inc. stock trending bullish2025 Earnings Impact & Verified Technical Signals - khodrobank.com
Analyzing recovery setups for AtriCure Inc. investors2025 Top Gainers & Weekly High Return Stock Forecasts - Newser
Live market analysis of AtriCure Inc.Market Activity Summary & Daily Technical Stock Forecast Reports - Newser
Price momentum metrics for AtriCure Inc. explainedPortfolio Return Report & Real-Time Market Sentiment Alerts - Newser
Strategies to average down on AtriCure Inc.Weekly Profit Summary & AI Powered Trade Plan Recommendations - Newser
What’s next for AtriCure Inc. stock priceJuly 2025 Market Mood & Real-Time Stock Movement Alerts - Newser
Will breakout in AtriCure Inc. lead to full recoveryPortfolio Risk Report & Free Long-Term Investment Growth Plans - Newser
Will AtriCure Inc. outperform the market in YEARJuly 2025 Technicals & Weekly Chart Analysis and Trade Guides - khodrobank.com
Chart based exit strategy for AtriCure Inc.Weekly Gains Summary & Safe Entry Point Identification - Newser
Using data filters to optimize entry into AtriCure Inc.Weekly Trend Report & AI Forecasted Stock Moves - Newser
Is AtriCure Inc. stock influenced by commodity pricesJuly 2025 Catalysts & Low Risk High Reward Ideas - khodrobank.com
What candlestick patterns are forming on AtriCure Inc.Analyst Upgrade & Free High Accuracy Swing Entry Alerts - Newser
What to expect from AtriCure Inc. in the next 30 days2025 Trade Ideas & Daily Profit Focused Stock Screening - Newser
What indicators show strength in AtriCure Inc.July 2025 Pullbacks & Capital Efficient Trade Techniques - Newser
Is AtriCure Inc. stock undervalued right nowGlobal Markets & High Win Rate Trade Tips - khodrobank.com
How much upside does AtriCure Inc. haveEarnings Recap Report & AI Enhanced Trading Signals - khodrobank.com
AtriCure Inc. Charts Flash Early Recovery Signals getLinesFromResByArray error: size == 0 - kangso.co.kr
Is AtriCure Inc.’s ROIC above industry averageMarket Volume Report & Comprehensive Market Scan Reports - khodrobank.com
Is AtriCure Inc. stock ready for a breakoutNew Guidance & Low Risk Entry Point Tips - Newser
Is AtriCure Inc. meeting your algorithmic filter criteriaStock Surge & Scalable Portfolio Growth Ideas - Newser
What momentum shifts mean for AtriCure Inc.Analyst Downgrade & High Conviction Trade Alerts - Newser
AtriCure Inc. Pullback Analyzed — Is It Time to ExitJuly 2025 Movers & High Conviction Investment Ideas - beatles.ru
What machine learning models say about AtriCure Inc.Gap Down & Stock Timing and Entry Methods - Newser
AtriCure Inc. stock prediction for this week2025 Support & Resistance & Growth Focused Stock Pick Reports - Newser
How AtriCure Inc. stock performs during market volatilityAnalyst Downgrade & Safe Swing Trade Setup Alerts - Newser
Will AtriCure Inc. continue its uptrend2025 Short Interest & Long-Term Growth Portfolio Plans - Newser
Atricure Inc Stock (ATRC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Atricure Inc Stock (ATRC) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
WEHRWEIN SVEN | Director |
Aug 22 '25 |
Sale |
37.00 |
5,000 |
185,000 |
34,374 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):